Need for innovation driving China IP changes
This article was originally published in Scrip
With China set to finalise major amendments to its patent law by the end of the year, expectations are rising that the country's intellectual property (IP) regime will move closer to international norms. Although concerns remain over enforcement, the intent is clearly to foster innovation, says one expert.
You may also be interested in...
New potential topical therapy in dermatitis space set to move towards Japan approval submission based on positive new results.
Japan approval for BTK inhibitor marks new indication but in a small niche market, while another clearance may help extend Latuda's commercial life.
Novel antibody-drug conjugate receives approval in Japan for second-line breast cancer, providing another push to Japanese firm’s strategic plan to build up its oncology operations.